Jessica Eng
Acute Care · Phoenix, AZNPI 1336477488
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 202 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 34 manufacturers, the largest accounting for just 11.8% — the pattern of someone who eats at a lot of different presentations.
Across 202 payments — averaging $19.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB, Inc.$474
- Eisai Inc.$428
- AbbVie$376
- AstraZeneca$357
- Teva Pharmaceuticals USA, Inc.$289
- Lilly USA, LLC$280
- plus $2K from 28 others
What the payments were for
- Food & beverage$4,027100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| UCB, Inc. | 30 | $474 |
| Eisai Inc. | 17 | $428 |
| AbbVie | 29 | $376 |
| AstraZeneca(2 entities) | 9 | $357 |
| Teva Pharmaceuticals USA, Inc. | 8 | $289 |
| Lilly USA, LLC | 13 | $280 |
| Pfizer | 27 | $274 |
| Argenx US, Inc. | 9 | $259 |
| Neurocrine Biosciences, Inc. | 7 | $146 |
| Amneal Pharmaceuticals LLC | 6 | $108 |
| Lundbeck LLC | 4 | $86 |
| Bristol Myers Squibb | 5 | $82 |
| Neurelis, Inc. | 4 | $74 |
| Octapharma USA, Inc. | 2 | $67 |
| Tonix Medicines, Inc. | 3 | $56 |
| Genentech USA, Inc. | 2 | $56 |
| Biogen | 3 | $55 |
| Springworks Therapeutics, Inc. | 2 | $53 |
| Jazz Pharmaceuticals Inc. | 2 | $51 |
| Axsome Therapeutics, Inc. | 2 | $49 |
| Inspire Medical Systems, Inc. | 2 | $47 |
| Otsuka America Pharmaceutical, Inc. | 2 | $46 |
| Vanda Pharmaceuticals Inc. | 2 | $41 |
| GE HealthCare | 2 | $40 |
| Cycle Pharmaceuticals Inc | 1 | $31 |
| EMD Serono, Inc. | 1 | $28 |
| Averitas Pharma Inc. | 1 | $26 |
| Xeris Pharmaceuticals, Inc. | 1 | $25 |
| SK Life Science, Inc. | 1 | $24 |
| Novartis | 1 | $24 |
| Acadia Pharmaceuticals Inc | 1 | $21 |
| Catalyst Pharmaceuticals, Inc. | 1 | $19 |
| Alnylam Pharmaceuticals Inc. | 1 | $19 |
| Azurity Pharmaceuticals, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ULTOMIRIS$122
How this compares
$4,027 in reported general payments places this provider in the 85th percentile of 482 acute care providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Carbidopa-LevodopaCarbidopa/Levodopa | 13 | $323 |
| Atorvastatin Calcium | 15 | $155 |
| RizatriptanRizatriptan Benzoate | 13 | $150 |
Paid to pharmacies, not to this prescriber.
Other acute care in Phoenix
- Kim KrmpoticPhoenix$79K
- Laura Cook-GongoraPhoenix$32K
- Cathy PaynePhoenix$26K
- Chandra SorrellePhoenix$16K
- Nicole RauscherPhoenix$12K
- Brooke GambinoPhoenix$11K
- Kelly WesselhoffPhoenix$9K
- Jenna GonzalesPhoenix$8K
- Kristen HudsonPhoenix$8K
- Tammy TyreePhoenix$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.